Sulfacetamide, Sulfur Topical Pad, Cleanser 10-2pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Sulfacetamide, Sulfur: Topical pad, cleanser (10-2%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
AVAR LS Cleansing Pad
Drug Image file default-drug-image.png
AVAR LS Cleansing Pad

What is this Medicine?

SULFACETAMIDE; SULFUR (sul fa SEE ta mide; sul fur) is a sulfonamide antibiotic. It is used on the skin to treat acne, rosacea, or seborrhea.

CVS Pharmacy Patient Statistics for Sulfacetamide, Sulfur: Topical pad, cleanser(10-2%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

AVAR LS 10%-2% Cleansing Pad

NDC: 001780640
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




Labeled but not FDA approved for the following conditions:
Acne Vulgaris, Acne Rosacea, Seborrheic Dermatitis

Storage Information
Protect from freezing
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Brief exposure up to 104 degrees F does not adversely affect product
Avoid excessive heat (above 104 degrees F)
AVAR LS 10%-2% Cleansing Pad

Reported Side Effects for AVAR LS 10%-2% Cleansing Pad

Allergic Skin Reaction Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hemolytic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
No White Blood Cells Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Photosensitivity Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Bruises Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Skin Redness Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Skin Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Sulfacetamide, Sulfur

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.